Organon’s workforce cuts come several months after the company’s loss of exclusivity to its second-largest product, Atozet.

there JERSEY CITY, N.J., December 16, 2024--Organon's VTAMA (tapinarof) cream is a first-in-class therapy with new FDA approval for atopic dermatitis in adults and children aged 2 and older.

Raymond James Financial Inc. acquired a new stake in Organon & Co. (NYSE:OGN – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and ...

JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN) today announced its results for the fourth quarter and full year ended December 31, 2024. “In 2024 we achieved our third year of constant ...

Organon has geographic scope with significant reach, world-class commercial capabilities, and approximately 10,000 employees with headquarters located in Jersey City, New Jersey. Except for ...

Most are optimistic about the change. With the acquisition, Organon brings nearly 3,000 new research and development employees to Schering-Plough's team of some 4,400. In addition, Organon's line of ...

Proficio Capital Partners LLC purchased a new stake in shares of ... and is headquartered in Jersey City, NJ. Receive News & Ratings for Organon & Co. Daily - Enter your email address below ...

Organon has geographic scope with significant reach, world-class commercial capabilities, and approximately 10,000 employees with headquarters located in Jersey City, New Jersey.

SHANGHAI, China & JERSEY CITY, NJ, USA I March 28, 2025 I Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) today announced that the ...